Market revenue in 2021 | USD 72.1 million |
Market revenue in 2030 | USD 133.1 million |
Growth rate | 7% (CAGR from 2021 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Preclinical |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preclinical, Clinical |
Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 66.16% in 2021. Horizon Databook has segmented the Canada large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Well-established healthcare infrastructure coupled with high healthcare expenditure in the country will boost market growth of large molecule bioanalytical testing in the country. For instance, according to Canadian Institute of Health Information, the total healthcare expenditure per person in Canada was USD 7,064 in 2019.
Such environment will augment the market for large molecule bioanalytical testing in the country. The biopharmaceutical pipeline of Canada covers various therapeutic fields, with innovative product candidates.
As of March 2017, there were around 158 biopharmaceutical small and medium enterprises offering more than 444 under development biopharmaceutical products for human health. Hence, robust biopharmaceutical product pipeline and suitable environment for clinical research are expected to augment market growth of large molecule bioanalytical testing.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada large molecule bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Canada large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account